Spatiotemporal variability in dengue transmission intensity in Jakarta, Indonesia
- PMID: 32142516
- PMCID: PMC7080271
- DOI: 10.1371/journal.pntd.0008102
Spatiotemporal variability in dengue transmission intensity in Jakarta, Indonesia
Abstract
Background: Approximately 70% of the global burden of dengue disease occurs on the Asian continent, where many large urban centres provide optimal environments for sustained endemic transmission and periodic epidemic cycles. Jakarta, the capital of Indonesia, is a densely populated megacity with hyperendemic dengue transmission. Characterization of the spatiotemporal distribution of dengue transmission intensity is of key importance for optimal implementation of novel control and prevention programmes, including vaccination. In this paper we use mathematical models to provide the first detailed description of spatial and temporal variability in dengue transmission intensity in Jakarta.
Methodology/principal findings: We applied catalytic models in a Bayesian framework to age-stratified dengue case notification data to estimate dengue force of infection and reporting probabilities in 42 subdistricts of Jakarta. The model was fitted to yearly and average annual data covering a 10-year period between 2008 and 2017. We estimated a long-term average annual transmission intensity of 0.130 (95%CrI: 0.129-0.131) per year in Jakarta province, ranging from 0.090 (95%CrI: 0.077-0.103) to 0.164 (95%CrI: 0.153-0.174) across subdistricts. Annual average transmission intensity in Jakarta province during the 10-year period ranged from 0.012 (95%CrI: 0.011-0.013) in 2017 to 0.124 (95%CrI: 0.121-0.128) in 2016.
Conclusions/significance: While the absolute number of dengue case notifications cannot be relied upon as a measure of endemicity, the age-distribution of reported dengue cases provides valuable insights into the underlying nature of transmission. Our estimates from yearly and average annual case notification data represent the first detailed estimates of dengue transmission intensity in Jakarta's subdistricts. These will be important to consider when assessing the population-level impact and cost-effectiveness of potential control and prevention programmes in Jakarta province, such as the controlled release of Wolbachia-carrying mosquitoes and vaccination.
Conflict of interest statement
SRH and HIS have been clinical trial and/or study investigators for, and received associated payments from, Sanofi Pasteur, a company involved in the development of dengue vaccines.
Figures
References
-
- Global strategy for dengue prevention and control, 2012–2020. [Internet]. World Health Organization; 2012 [cited 2019 Jun 28]. 35 p. Available from: https://www.who.int/denguecontrol/9789241504034/en/
-
- Gubler DJ. Dengue, Urbanization and Globalization: The Unholy Trinity of the 21(st) Century. Trop Med Health [Internet]. 2011. December [cited 2017 Jul 4];39(4 Suppl):3–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22500131 10.2149/tmh.2011-S05 - DOI - PMC - PubMed
-
- Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature [Internet]. 2013. April 7 [cited 2017 Jul 4];496(7446):504–7. Available from: http://www.nature.com/doifinder/10.1038/nature12060 - DOI - PMC - PubMed
-
- WAHYONO TYM, NEALON J, BEUCHER S, PRAYITNO A, MOUREAU A, NAWAWI S, et al. Indonesian dengue burden estimates: review of evidence by an expert panel. Epidemiol Infect [Internet]. 2017. May 26 [cited 2017 Jul 3];1–6. Available from: https://www.cambridge.org/core/product/identifier/S0950268817001030/type... - PMC - PubMed
-
- Prayitno A, Taurel A-F, Nealon J, Satari HI, Karyanti MR, Sekartini R, et al. Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian children. G?rtler RE, editor. PLoS Negl Trop Dis [Internet]. 2017. June 15 [cited 2017 Jul 4];11(6):e0005621 Available from: 10.1371/journal.pntd.0005621 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
